Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome Changes With Topical Medications
NCT03437005Phase 1Recruiting
- Sponsor
- University of California, Davis
- Start
- Jan 2013
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1 trial of desonide and Ketoconazole Cream in seborrheic dermatitis (SD), atopic dermatitis (AD) and psoriasis (2 arms), sponsored by University of California, Davis. Primary endpoint: Number of bacteria per each species at 2 weeks. Started Jan 2013; status: recruiting.
02
Drugs
desonideKetoconazole Cream
03
Conditions
seborrheic dermatitis (SD)atopic dermatitis (AD)psoriasis
Beyond the preview
Go deeper on NCT03437005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03437005.